Dopamine beta-hydroxylase

From WikiMD's Wellness Encyclopedia

Dopamine beta-hydroxylase (DBH), also known as dopamine beta-monooxygenase, is an enzyme that catalyzes the conversion of dopamine to norepinephrine.

Function[edit | edit source]

DBH is a copper-containing oxygenase that exists as a tetramer with four identical subunits. It is located in the synaptic vesicles of postganglionic sympathetic neurons and in adrenal medulla, where it converts dopamine to norepinephrine. This conversion is a critical step in the sympathetic nervous system's production of norepinephrine, which plays a key role in the body's fight or flight response.

Clinical significance[edit | edit source]

Mutations in the DBH gene can lead to Dopamine beta hydroxylase deficiency, a condition characterized by a lack of norepinephrine and epinephrine in patients. Symptoms can include orthostatic hypotension, ptosis, and nasal stuffiness.

See also[edit | edit source]

References[edit | edit source]


External links[edit | edit source]

Dopamine beta-hydroxylase Resources

Contributors: Prab R. Tumpati, MD